Skip Navigation
ChemIDplus LiteBrowseAdvanced

Substance Name: TBO-Filgrastim
ID: S900006000


  • FDA: Tbo-filgrastim is intended for use in adults who have cancers other than blood or bone marrow cancers (non-myeloid malignancies) and are taking chemotherapy drugs that cause a substantial decrease in the production of neutrophils in the bone marrow. This reduction in neutrophils may lead to infection and fever (febrile neutropenia).

    Tbo-filgrastim stimulates the bone marrow to increase the production of neutrophils. It is administered as an injection beginning 24 hours after chemotherapy treatment. [Press Release]
* denotes mobile formatted website

Links to Resources

Names and Synonyms

Name of Substance

  • TBO-Filgrastim


  • Granix
  • TBO Filgrastim
  • TBO-Filgrastim
  • XM02 Filgrastim

Registry Number

  • S900006000